SC
SCL
—
NYSE
Oil & Gas Exploration & Production
Stepan Co
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
1,2B USD
P/E
25,1x
EV / Rev
0,7x
Div yield
3,02 %
Op margin
3,4 %
ROE
3,9 %
Net margin
2,0 %
Debt / equity
0,55
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
$65,07
Open
—
Next earnings
2026-10-28
Ex-dividend
—
TR 1Y
—
About
Stepan Company manufactures and markets specialty chemicals, primarily surfactants and polymers, for industrial and consumer applications.
Business. Stepan Company manufactures and markets specialty chemicals, primarily surfactants and polymers, for industrial and consumer applications.
Classification77 %
SectorEnergy
Business sectorOil & Gas
IndustryOil & Gas Exploration & Production
ActivityExploration & Production
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
At a glance
Score
—
not yet scored
Valuation→
25,1x
P/E
Analysts
—
not yet wired
Ownership→
American Century Investment Management, Inc.
largest disclosed fund holder
Profitability→
3,9 %
return on equity
Quality
—
not yet scored
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
— missing data
News & coverage
0Sector rotation
Sector1D1Mvs mkt
Materials+2,3 %+6,7 %+1,7 %
Communication Services+2,2 %−5,5 %+1,6 %
Health Care+0,6 %−0,8 %+0,0 %
Energy · THIS SECTOR+0,6 %+3,3 %+0,0 %
Consumer Discretionary+0,4 %+7,6 %−0,2 %
Information Technology+0,2 %+7,9 %−0,4 %
Financials−0,3 %−3,0 %−1,0 %
Consumer Staples−0,7 %+2,5 %−1,3 %
Real Estate−0,7 %+10,9 %−1,3 %
Industrials−1,8 %−1,6 %−2,4 %
Utilities−1,9 %+28,2 %−2,5 %
Developing storylines
No tracked sagas currently linked to SCL. Browse all sagas →
Analysis
AI analysis
Generated · analysis pipeline · tier hybrid · as of 2026-08-01
↑ At a glance
Opportunity
— missing data
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
— missing data
Signals & dispatch
peak dispatch · —
Composite-score breakdown
Synthesis
Business
Stepan Company manufactures and markets specialty chemicals, primarily surfactants and polymers, for industrial and consumer applications.
Classification77 %
SectorEnergy
Business sectorOil & Gas
IndustryOil & Gas Exploration & Production
ActivityExploration & Production
AI synthesis
GENERATEDStepan Company maintains a conservative capital structure with a debt-to-equity ratio of 0.55 and a current ratio of 1.26. Total debt stands at $651.7 million, comprising $328.4 million in long-term debt and $323.3 million in short-term obligations, against total equity of $1.19 billion. The company holds $140.8 million in cash and equivalents, resulting in a negative net cash position. Operating cash flow for Q1 2026 was $16.9 million, while free cash flow was negative $14.0 million due to $30.9 million in capital expenditures.
Profitability metrics indicate operational pressure, with a return on equity of 3.93% and return on assets of 2.01%. The company reported a net loss of $41.4 million on revenue of $604.5 million, driven by an operating loss of $49.6 million. Gross profit was $64.9 million, yielding a gross margin of approximately 10.7%. The valuation snapshot shows a P/E ratio of 25.09 and an EV/EBITDA of 8.25, reflecting the market's pricing of current earnings volatility.
Revenue generation is diversified across segments including Surfactants, Polymers, and Specialty Products, with geographic exposure spanning North America, Europe, Latin America, and Asia. The filing observations reference specific reporting units such as the European Polymers Reporting Unit and Colombia Reporting Unit, indicating a global operational footprint. Competition is based on product performance, price, technical assistance, and capacity availability.
Growth trajectory analysis is limited by the absence of historical period data in the input. The Q1 2026 revenue of $604.5 million serves as the baseline for current performance assessment. Without prior period comparisons, year-over-year growth rates cannot be calculated from the provided data.
Risk factors include medium liquidity risk and unknown dilution risk due to missing basic and diluted share count assessments. Key flags highlight negative net cash and the inability to assess dilution risk. The company faces operational risks including raw material cost volatility, supply disruptions, and compliance with environmental and safety regulations.
Recent events include a significant stock price movement on July 29, 2026, with a 15.07% single-day gain to $66.75 on volume 4.33 times the 20-day average. Filing observations note $62.4 million in restructuring costs during Q1 2026, including asset impairment charges at the Fieldsboro, New Jersey ($43.0 million), Elwood, Illinois ($14.3 million), and Stalybridge, U.K. ($5.1 million) sites. Analyst consensus shows a mean price target of $75.00 with a mean recommendation of 2.00 (Buy).
Key takeaways
- Q1 2026 net loss of $41.4 million driven by $62.4 million in restructuring and impairment charges.
- Conservative balance sheet with 0.55 debt-to-equity ratio but negative free cash flow of $14.0 million.
- Significant stock price appreciation of 15.07% on July 29, 2026, with volume 4.33x average.
- Analyst consensus targets $75.00, implying upside from the $51.40 market price in the valuation snapshot.
- Operational risks include raw material volatility and global supply chain disruptions.
- Dilution risk remains unassessed due to missing share count data in the risk assessment.
Bull / Bear case
Generated · model-assisted— missing data
In focus — financials by report
Quarterly
Annual
QUARTERLYFiled 2026-03-31
Q4 2025 · Quarter highlights
Revenue $604.5M; Operating income -$49.6M.
Revenue$604.5M
Operating income-$49.6M
Net income-$41.4M
Free cash flow-$14.0M
EPS—
Operating cash flow$16.9M
Financials
Income statement
Revenue$604.5M
Gross profit$64.9M
Operating income-$49.6M
Net income-$41.4M
Margins
Gross margin10.7%
Operating margin-8.2%
Net margin-6.8%
FCF margin-2.3%
Balance sheet
Total assets$2.33B
Total liabilities—
Total equity$1.19B
Cash & equivalents$140.8M
Long-term debt$328.4M
Cash flow
Operating cash flow$16.9M
CapEx$30.9M
Free cash flow-$14.0M
SBC$1.5M
P&L flow · revenue → net income
Highlights
- ▍Revenue $604.5M
- ▍Operating income -$49.6M
- ▍Net margin -6.8%
QUARTERLYFiled 2025-09-30
Q2 2025 · Quarter highlights
Revenue $1.78B; Operating income $68.0M.
Revenue$1.78B
Operating income$68.0M
Net income$41.9M
Free cash flow-$5.0k
EPS—
Operating cash flow$87.9M
Financials
Income statement
Revenue$1.78B
Gross profit$218.4M
Operating income$68.0M
Net income$41.9M
Margins
Gross margin12.3%
Operating margin3.8%
Net margin2.4%
FCF margin-0.0%
Balance sheet
Total assets$2.43B
Total liabilities—
Total equity$1.25B
Cash & equivalents$118.5M
Long-term debt$357.1M
Cash flow
Operating cash flow$87.9M
CapEx$87.9M
Free cash flow-$5.0k
SBC$4.5M
P&L flow · revenue → net income
Highlights
- ▍Revenue $1.78B
- ▍Operating income $68.0M
- ▍Net margin 2.4%
QUARTERLYFiled 2025-06-30
Q1 2025 · Quarter highlights
Revenue $1.19B; Operating income $46.3M.
Revenue$1.19B
Operating income$46.3M
Net income$31.1M
Free cash flow-$40.2M
EPS—
Operating cash flow$18.1M
Financials
Income statement
Revenue$1.19B
Gross profit$147.3M
Operating income$46.3M
Net income$31.1M
Margins
Gross margin12.4%
Operating margin3.9%
Net margin2.6%
FCF margin-3.4%
Balance sheet
Total assets$2.42B
Total liabilities—
Total equity$1.24B
Cash & equivalents$88.9M
Long-term debt$383.2M
Cash flow
Operating cash flow$18.1M
CapEx$58.3M
Free cash flow-$40.2M
SBC$3.1M
P&L flow · revenue → net income
Highlights
- ▍Revenue $1.19B
- ▍Operating income $46.3M
- ▍Net margin 2.6%
ANNUALFiled 2025-12-31
FY 2025 · Full-year highlights
Revenue $2.33B; Operating income $78.5M.
Revenue$2.33B
Operating income$78.5M
Net income$46.9M
Free cash flow$25.4M
EPS—
Operating cash flow$147.9M
Financials
Income statement
Revenue$2.33B
Gross profit$269.9M
Operating income$78.5M
Net income$46.9M
Margins
Gross margin11.6%
Operating margin3.4%
Net margin2.0%
FCF margin1.1%
Balance sheet
Total assets$2.36B
Total liabilities—
Total equity$1.24B
Cash & equivalents$132.7M
Long-term debt$341.0M
Cash flow
Operating cash flow$147.9M
CapEx$122.5M
Free cash flow$25.4M
SBC$6.0M
P&L flow · revenue → net income
Highlights
- ▍Revenue $2.33B
- ▍Operating income $78.5M
- ▍Net margin 2.0%
ANNUALFiled 2024-12-31
FY 2024 · Full-year highlights
Revenue $2.18B; Operating income $70.5M.
Revenue$2.18B
Operating income$70.5M
Net income$50.4M
Free cash flow$39.3M
EPS—
Operating cash flow$162.1M
Financials
Income statement
Revenue$2.18B
Gross profit$272.2M
Operating income$70.5M
Net income$50.4M
Margins
Gross margin12.5%
Operating margin3.2%
Net margin2.3%
FCF margin1.8%
Balance sheet
Total assets$2.30B
Total liabilities—
Total equity$1.17B
Cash & equivalents$99.7M
Long-term debt$332.6M
Cash flow
Operating cash flow$162.1M
CapEx$122.8M
Free cash flow$39.3M
SBC$5.3M
P&L flow · revenue → net income
Highlights
- ▍Revenue $2.18B
- ▍Operating income $70.5M
- ▍Net margin 2.3%
ANNUALFiled 2024-12-31
FY 2025 · Full-year highlights
Revenue $2.18B; Operating income $70.5M.
Revenue$2.18B
Operating income$70.5M
Net income$50.4M
Free cash flow$39.3M
EPS—
Operating cash flow$162.1M
Financials
Income statement
Revenue$2.18B
Gross profit$272.2M
Operating income$70.5M
Net income$50.4M
Margins
Gross margin12.5%
Operating margin3.2%
Net margin2.3%
FCF margin1.8%
Balance sheet
Total assets$2.30B
Total liabilities—
Total equity$1.17B
Cash & equivalents$99.7M
Long-term debt$332.6M
Cash flow
Operating cash flow$162.1M
CapEx$122.8M
Free cash flow$39.3M
SBC$5.3M
P&L flow · revenue → net income
Highlights
- ▍Revenue $2.18B
- ▍Operating income $70.5M
- ▍Net margin 2.3%
ANNUALFiled 2023-12-31
FY 2023 · Full-year highlights
Revenue $2.33B; Operating income $58.6M.
Revenue$2.33B
Operating income$58.6M
Net income$40.2M
Free cash flow-$85.5M
EPS—
Operating cash flow$174.9M
Financials
Income statement
Revenue$2.33B
Gross profit$277.6M
Operating income$58.6M
Net income$40.2M
Margins
Gross margin11.9%
Operating margin2.5%
Net margin1.7%
FCF margin-3.7%
Balance sheet
Total assets$2.36B
Total liabilities—
Total equity$1.22B
Cash & equivalents$129.8M
Long-term debt$401.2M
Cash flow
Operating cash flow$174.9M
CapEx$260.3M
Free cash flow-$85.5M
SBC$5.7M
P&L flow · revenue → net income
Highlights
- ▍Revenue $2.33B
- ▍Operating income $58.6M
- ▍Net margin 1.7%
ANNUALFiled 2023-12-31
FY 2024 · Full-year highlights
Revenue $2.33B; Operating income $58.6M.
Revenue$2.33B
Operating income$58.6M
Net income$40.2M
Free cash flow-$85.5M
EPS—
Operating cash flow$174.9M
Financials
Income statement
Revenue$2.33B
Gross profit$277.6M
Operating income$58.6M
Net income$40.2M
Margins
Gross margin11.9%
Operating margin2.5%
Net margin1.7%
FCF margin-3.7%
Balance sheet
Total assets$2.36B
Total liabilities—
Total equity$1.22B
Cash & equivalents$129.8M
Long-term debt$401.2M
Cash flow
Operating cash flow$174.9M
CapEx$260.3M
Free cash flow-$85.5M
SBC$5.7M
P&L flow · revenue → net income
Highlights
- ▍Revenue $2.33B
- ▍Operating income $58.6M
- ▍Net margin 1.7%
Valuation FY
Market price
$51,40
Market cap
$1.18B
Enterprise valueⓘ
$1.69B
P/Eⓘ
25.1x
Non-GAAP P/Eⓘ
—
EV / Revenueⓘ
0.7x
EV / Op incomeⓘ
21.5x
EV / OCFⓘ
11.4x
P / Bⓘ
—
P / Tangible bookⓘ
—
Tangible book
—
Net cashⓘ
-$510.9M
Current ratioⓘ
1.3
Debt / equityⓘ
0.6
ROAⓘ
2.0%
ROEⓘ
3.9%
Cash conversionⓘ
315.0%
CapEx / revenueⓘ
5.2%
SBC / revenueⓘ
0.3%
Dilution ratioⓘ
—
Revenue by segment
Business relationships
— missing data
Supply chain
— missing data
Peer comparison
— missing data
Market position
Stress test
— missing data
Predictor forecast
Options
— missing data
Short squeeze
— missing data
Earnings-call key lines
— missing data
Consensus distribution
sell-side coverageRecommendation distribution1 analysts
Strong buy0
Buy1
Hold0
Sell0
Strong sell0
12-month price target$75,00 · Median $75,00
Low $75,00High $75,00
Operating income · consensus106,9M USD
EPS surprise
−33,2 %
reported vs consensus · miss
Revenue surprise
−8,2 %
reported vs consensus · miss
Estimate revisions
consensus EPS · 26-week trend— missing data
Sell-side observations
Low$75,00
Mean$75,00
Median$75,00
High$75,00
Spot$51,40
+45.9 %implied to mean12-month sell-side price targets · ▲ spot
Themes
— missing data
ESG
— missing data
Risk factors
Dilution riskUnknown
Liquidity riskMedium
Filing-based flags
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Op Margin3,4 %Bottom quartile
Net Margin2,0 %Bottom quartile
ROE3,9 %Below median
Capex / Rev5,2 %Above P75
D/E0,55Below median
Cash Conv3,15Above P75
Corporate actions / M&A
— missing data
FX exposure
— missing data
Comparable transactions
— missing data
Derivatives & instruments
Derivative transactions
Net acquired 210 712 sh11 exercises · 27 grants9 insiders
- VP and GM Surfactants-INT · Restricted Stock Units → Restricted Stock UnitsDisposed 90exercise · 2026-05-11
- EVP, Supply Chain · Restricted Stock Units → Restricted Stock UnitsDisposed 550exercise · 2026-05-01
- VP and GM Surfactants NA · Restricted Stock Units → Restricted Stock UnitsAcquired 2 621grant · 2026-04-13
- VP and GM Surfactants-INT · Stock Appreciation Right → Common StockAcquired 4 030 @ $52,46grant · 2026-04-13
- VP and GM Surfactants-INT · Restricted Stock Units → Restricted Stock UnitsAcquired 2 859grant · 2026-04-13
- VP and GM Surfactants-INT · Performance Shares → Common StockAcquired 1 429grant · 2026-04-13
- VP and GM Surfactants NA · Performance Shares → Common StockAcquired 1 310grant · 2026-04-13
- VP and GM Surfactants NA · Stock Appreciation Right → Common StockAcquired 3 694 @ $52,46grant · 2026-04-13
- Director, President & CEO · Restricted Stock Units → Restricted Stock UnitsDisposed 857exercise · 2026-03-04
- V.P. and Gen'l. Mgr., Polymers · Restricted Stock Units → Restricted Stock UnitsDisposed 429exercise · 2026-03-04
- EVP, Supply Chain · Restricted Stock Units → Restricted Stock UnitsDisposed 571exercise · 2026-03-04
- VP & GM Surfactants · Restricted Stock Units → Restricted Stock UnitsDisposed 571exercise · 2026-03-04
- VP & GM Surfactants · Restricted Stock Units → Restricted Stock UnitsDisposed 1 670exercise · 2026-03-03
- Director, President & CEO · Restricted Stock Units → Common StockDisposed 4 455exercise · 2026-03-03
- EVP, Supply Chain · Restricted Stock Units → Restricted Stock UnitsDisposed 1 670exercise · 2026-03-03
- V.P. and Gen'l. Mgr., Polymers · Restricted Stock Units → Common StockDisposed 1 253exercise · 2026-03-03
- Director, President & CEO · Stock Appreciation Right → Common StockAcquired 57 241 @ $17,47grant · 2026-03-02
- VP GC & Secretary · Restricted Stock Units → Restricted Stock UnitsAcquired 4 495grant · 2026-03-02
- VP GC & Secretary · Performance Shares → Common StockAcquired 2 247grant · 2026-03-02
- VP GC & Secretary · Stock Appreciation Right → Common StockAcquired 6 440 @ $17,47grant · 2026-03-02
- VP & CHRO · Restricted Stock Units → Restricted Stock UnitsAcquired 4 495grant · 2026-03-02
- VP & CHRO · Performance Shares → Common StockAcquired 2 247grant · 2026-03-02
- VP & CHRO · Stock Appreciation Right → Common StockAcquired 6 440 @ $17,47grant · 2026-03-02
- EVP, Supply Chain · Restricted Stock Units → Restricted Stock UnitsAcquired 5 993grant · 2026-03-02
- EVP, Supply Chain · Performance Shares → Common StockAcquired 2 996grant · 2026-03-02
Actions
Ask Handelsavisen
— missing data
Data sources
- Market data
- Regulatory filings
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
How metrics are computed
- Cash Conversion Ratiooperating_cash_flow / net_income
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Ev To Revenueenterprise_value / revenue
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Market Capmarket_price * shares_outstanding_diluted
Source documents
- STEPAN CO company facts · 2026-08-01
- STEPAN CO 10-Q 2026-05-06 · 2026-08-01
- STEPAN CO 10-K 2026-02-26 · 2026-08-01
- STEPAN CO 10-Q 2025-11-05 · 2026-08-01
- STEPAN CO 10-Q 2025-08-06 · 2026-08-01
- ha_price_move fired on SCL · 2026-08-01
- Stepan Co Market data — analyst estimates · 2026-08-01
- Stepan Co Market data — ESG · 2026-08-01
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,02 %$37M
- Investment Managers · as of 2026-03-310,01 %$56M
- Investment Managers · as of 2024-06-300,01 %$281M
- Investment Managers · as of 2026-03-310,01 %$12M
- Institutional Investor · as of 2026-03-310,00 %$20M
- Investment Managers · as of 2026-03-310,00 %$23M
- Investment Managers · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2025-12-310,00 %$122M
- Investment Managers · as of 2024-12-310,00 %$6M
- Investment Managers · as of 2026-03-310,00 %$13M
- Investment Managers · as of 2026-03-310,00 %$26M
- Investment Managers · as of 2026-03-310,00 %$12M
- Investment Managers · as of 2026-03-310,00 %$45M
- Funds · as of 2026-03-310,00 %$9M
- Institutional Investor · as of 2026-03-310,00 %$6M
- Investment Managers · as of 2026-03-310,00 %$15M
- Investment Managers · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
Insider activity
Mixed / flat0 buys · 0 sellsnet $015 insiders · last 365d
- VP and GM Surfactants-INT · Common StockOther 90 @ $52,58$5K · 2026-05-11
- VP and GM Surfactants-INT · Common StockOther 50 @ $52,58$3K · 2026-05-11
- Director · Common StockOther 2 566 @ $52,61$135K · 2026-05-08
- Director · Common StockOther 2 566 @ $52,61$135K · 2026-05-08
- Director · Common StockOther 2 566 @ $52,61$135K · 2026-05-08
- Director · Common StockOther 2 566 @ $52,61$135K · 2026-05-08
- Director · Common StockOther 2 566 @ $52,61$135K · 2026-05-08
- Director · Common StockOther 2 566 @ $52,61$135K · 2026-05-08
- Director · Common StockOther 2 566 @ $52,61$135K · 2026-05-08
- EVP, Supply Chain · Common StockOther 550 @ $50,33$28K · 2026-05-01
- EVP, Supply Chain · Common StockOther 162 @ $50,33$8K · 2026-05-01
- V.P. and Gen'l. Mgr., Polymers · Common StockOther 149 @ $49,62$7K · 2026-03-04
- V.P. and Gen'l. Mgr., Polymers · Common StockOther 429 @ $49,62$21K · 2026-03-04
- Director, President & CEO · Common StockOther 857 @ $49,62$43K · 2026-03-04
- Director, President & CEO · Common StockOther 252 @ $49,62$13K · 2026-03-04
- EVP, Supply Chain · Common StockOther 571 @ $49,62$28K · 2026-03-04
- EVP, Supply Chain · Common StockOther 168 @ $49,62$8K · 2026-03-04
- VP & GM Surfactants · Common StockOther 166 @ $49,62$8K · 2026-03-04
- VP & GM Surfactants · Common StockOther 571 @ $49,62$28K · 2026-03-04
- EVP, Supply Chain · Common StockOther 1 670 @ $48,98$82K · 2026-03-03
- EVP, Supply Chain · Common StockOther 490 @ $48,98$24K · 2026-03-03
- VP & GM Surfactants · Common StockOther 570 @ $48,98$28K · 2026-03-03
- VP & GM Surfactants · Common StockOther 1 670 @ $48,98$82K · 2026-03-03
- V.P. and Gen'l. Mgr., Polymers · Common StockOther 434 @ $48,98$21K · 2026-03-03
- V.P. and Gen'l. Mgr., Polymers · Common StockOther 1 253 @ $48,98$61K · 2026-03-03
Short positioning
604.3Kshares short-6.0% vs prior
4.82days to cover
65.9%short of daily vol
144fails-to-deliver
as of 2026-07-15 · short-interest report (free)
Geographic breakdown
— missing data
Listings · one canonical issuer
all listings resolve to the canonical
SCLCanonical
NYSE · USD
Intel & risk
peak dispatch · —
OSINT findings
Dilution riskUnknown
Liquidity riskMedium
Net cash is negative after subtracting total debt.
Evidence & claims
From filings & derived data- Net income (YoY) (2025-12-31 vs 2024-12-31): -6.9%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): 11.4%Derived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 0.2%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 6.3%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 7.0%Derived (calculated)
- Gross profit (YoY) (2025-12-31 vs 2024-12-31): -0.9%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -6.8%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -7.2%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 8.1%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 3.7%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 33.1%Derived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): -0.2%Derived (calculated)
- Return on assets (FY 2025-12-31): 2.0%Derived (calculated)
- Current ratio (FY 2025-12-31): 1.29xDerived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -8.7%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 2.3%Derived (calculated)
- Net margin (FY 2025-12-31): 2.0%Derived (calculated)
- Gross margin (FY 2025-12-31): 11.6%Derived (calculated)
- Return on equity (FY 2025-12-31): 3.8%Derived (calculated)
- Cost of revenue (annual): USD 2.06BSEC XBRL filing
- R&D expense (annual): USD 34.8MSEC XBRL filing
- Revenue (annual): USD 2.33BSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES 2SEC XBRL filing
- Net income (annual): USD 46.9MSEC XBRL filing
Showing 24 of 60 surfaced claims.
Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.
The Thread
Everything we know, in order— missing data
Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-01
Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data
Premium coverage